Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing
暂无分享,去创建一个
S. Bhaskar | S. Banka | S. Douzgou | C. Hendriksz | A. Broomfield | S. Senniappan | E. Jameson | E. Crushell | S. Ramsden | J. Walter | Reena Sharma | A. A. Monavari | J. Urquhart | B. Schwahn | G. Wilcox | Arunabha Ghosh | H. Schlecht | Helen R Murphy | A. Morris | A. Doolan | L. Heptinstall | Simon A. Jones | Simon A Jones | A. Ghosh | J. Bassett | Richard M. Martin | E. Cartwright
[1] V. Tiranti,et al. New genes and pathomechanisms in mitochondrial disorders unraveled by NGS technologies. , 2016, Biochimica et biophysica acta.
[2] Ulrich Brandt,et al. Mutations in Complex I Assembly Factor TMEM126B Result in Muscle Weakness and Isolated Complex I Deficiency. , 2016, American journal of human genetics.
[3] Rafael Artuch,et al. Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism , 2016, PloS one.
[4] Andrea Superti-Furga,et al. Exome Sequencing and the Management of Neurometabolic Disorders. , 2016, The New England journal of medicine.
[5] I. C. Lloyd,et al. Molecular findings from 537 individuals with inherited retinal disease , 2016, Journal of Medical Genetics.
[6] A. Shaag,et al. Homozygous mutation in the APOA1BP is associated with a lethal infantile leukoencephalopathy , 2016, neurogenetics.
[7] S. Ferdinandusse,et al. The important role of biochemical and functional studies in the diagnostics of peroxisomal disorders , 2016, Journal of Inherited Metabolic Disease.
[8] L. Wong,et al. Added value of next generation gene panel analysis for patients with elevated methylmalonic acid and no clinical diagnosis following functional studies of vitamin B12 metabolism. , 2016, Molecular genetics and metabolism.
[9] W. Yue,et al. Role of reverse phenotyping in interpretation of next generation sequencing data and a review of INPP5E related disorders. , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[10] A. Hoischen,et al. TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation. , 2016, American journal of human genetics.
[11] A. Hoischen,et al. CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation. , 2016, American journal of human genetics.
[12] Eric E. Schadt,et al. A Next Generation Multiscale View of Inborn Errors of Metabolism. , 2016, Cell metabolism.
[13] I. Banerjee,et al. Recognition, assessment and management of hypoglycaemia in childhood , 2015, Archives of Disease in Childhood.
[14] E. Puffenberger,et al. Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8. , 2015, American journal of human genetics.
[15] Gert Matthijs,et al. Guidelines for diagnostic next-generation sequencing , 2015, European Journal of Human Genetics.
[16] Marjolein Kriek,et al. Next‐Generation Diagnostics: Gene Panel, Exome, or Whole Genome? , 2015, Human mutation.
[17] M. Baumgartner,et al. Insights into Severe 5,10‐Methylenetetrahydrofolate Reductase Deficiency: Molecular Genetic and Enzymatic Characterization of 76 Patients , 2015, Human mutation.
[18] William A Gahl,et al. Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors. , 2015, Human molecular genetics.
[19] D. Horn,et al. Mutations in NDUFB11, encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome. , 2015, American journal of human genetics.
[20] S. Gabriel,et al. Exome Sequencing in Suspected Monogenic Dyslipidemias , 2015, Circulation. Cardiovascular genetics.
[21] Richard J. Rodenburg,et al. Whole exome sequencing of suspected mitochondrial patients in clinical practice , 2015, Journal of Inherited Metabolic Disease.
[22] T. Meitinger,et al. CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorder. , 2015, American journal of human genetics.
[23] Edwin Cuppen,et al. Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects , 2015, European Journal of Human Genetics.
[24] Pontus Larsson,et al. Rapid pulsed whole genome sequencing for comprehensive acute diagnostics of inborn errors of metabolism , 2014, BMC Genomics.
[25] H. Prokisch,et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. , 2014, Molecular genetics and metabolism.
[26] M. Castro‐Gago,et al. Exome sequencing identifies a CHKB mutation in Spanish patient with megaconial congenital muscular dystrophy and mtDNA depletion. , 2014, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[27] E. Holme,et al. Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome , 2014, Molecular genetics & genomic medicine.
[28] Yuan Xue,et al. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing , 2014, Genetics in Medicine.
[29] W. Sessa,et al. Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation. , 2014, Cell metabolism.
[30] Beril Talim,et al. Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. , 2014, JAMA.
[31] J. Hughes,et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. , 2014, The Journal of allergy and clinical immunology.
[32] C. V. van Karnebeek,et al. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. , 2014, Molecular genetics and metabolism.
[33] J. Shendure,et al. A new congenital disorder of glycosylation caused by a mutation in SSR4, the signal sequence receptor 4 protein of the TRAP complex. , 2014, Human molecular genetics.
[34] A. Hoischen,et al. Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency. , 2014, Brain : a journal of neurology.
[35] Katherine R. Smith,et al. A founder mutation in PET100 causes isolated complex IV deficiency in Lebanese individuals with Leigh syndrome. , 2014, American journal of human genetics.
[36] N. Matsumoto,et al. A hemizygous GYG2 mutation and Leigh syndrome: a possible link? , 2014, Human Genetics.
[37] Y. Wada,et al. De Novo Mutations in SLC35A2 Encoding a UDP‐Galactose Transporter Cause Early‐Onset Epileptic Encephalopathy , 2013, Human mutation.
[38] H. Freeze,et al. Mutations in STT3A and STT3B cause two congenital disorders of glycosylation. , 2013, Human molecular genetics.
[39] G. Enns,et al. Mutations in the complex III assembly factor tetratricopeptide 19 gene TTC19 are a rare cause of Leigh syndrome , 2013 .
[40] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[41] M. Zeviani,et al. A Homozygous Mutation in LYRM7/MZM1L Associated with Early Onset Encephalopathy, Lactic Acidosis, and Severe Reduction of Mitochondrial Complex III Activity , 2013, Human mutation.
[42] Marni J. Falk,et al. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy. , 2013, American journal of human genetics.
[43] Lora J. H. Bean,et al. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing. , 2013, Molecular genetics and metabolism.
[44] R. Wevers,et al. Intellectual disability and bleeding diathesis due to deficient CMP–sialic acid transport , 2013, Neurology.
[45] M. Hurles,et al. NDUFA4 Mutations Underlie Dysfunction of a Cytochrome c Oxidase Subunit Linked to Human Neurological Disease , 2013, Cell reports.
[46] W. Newman,et al. A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations , 2013, Orphanet Journal of Rare Diseases.
[47] V. Mootha,et al. Targeted exome sequencing of suspected mitochondrial disorders , 2013, Neurology.
[48] Roderick F A Houben. The Treatable Intellectual Disability App: a Digital Tool to Enhance Diagnosis & Care for Rare Diseases. , 2013 .
[49] C. Alexander Valencia,et al. Comprehensive Mutation Analysis for Congenital Muscular Dystrophy: A Clinical PCR-Based Enrichment and Next-Generation Sequencing Panel , 2013, PloS one.
[50] Nicholas W. Wood,et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling , 2012, Bioinform..
[51] C. V. van Karnebeek,et al. The treatable intellectual disability APP www.treatable-id.org: A digital tool to enhance diagnosis & care for rare diseases , 2012, Orphanet Journal of Rare Diseases.
[52] Sylvia Stockler,et al. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. , 2012, Molecular genetics and metabolism.
[53] Madhuri R Hegde,et al. Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation , 2011, Genetics in Medicine.
[54] Hugo A. Katus,et al. Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of Cardiomyopathies , 2011, Circulation. Cardiovascular genetics.
[55] J. Berg,et al. Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: Implications for application to clinical testing , 2011, Genetics in Medicine.
[56] Christopher M. Clouthier,et al. Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. , 2011, American journal of human genetics.
[57] C. Willoughby,et al. Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa , 2010, Journal of Medical Genetics.
[58] M. Baumgartner,et al. Causes of and diagnostic approach to methylmalonic acidurias , 2008, Journal of Inherited Metabolic Disease.
[59] J. Tolmie,et al. Investigation of global developmental delay , 2006, Archives of Disease in Childhood.
[60] M. Preece,et al. The incidence of inherited metabolic disorders in the West Midlands, UK , 2006, Archives of Disease in Childhood.
[61] A Green,et al. Developmental delay: when to suspect and how to investigate for an inborn error of metabolism , 2005, Archives of Disease in Childhood.
[62] A. Ballabio,et al. Molecular and functional analysis of SUMF1 mutations in multiple sulfatase deficiency , 2004, Human mutation.
[63] J. Leonard,et al. The significance of a high plasma ammonia value , 2004, Archives of Disease in Childhood.
[64] D. Applegarth,et al. Incidence of Inborn Errors of Metabolism in British Columbia, 1969–1996 , 2000, Pediatrics.
[65] J. Leonard,et al. Evaluation of fasts for investigating hypoglycaemia or suspected metabolic disease. , 1996, Archives of disease in childhood.
[66] F. Alkuraya,et al. Mutation of the mitochondrial carrier SLC25A42 causes a novel form of mitochondrial myopathy in humans , 2015, Human Genetics.
[67] F. de Zegher,et al. Bone Dysplasia as a Key Feature in Three Patients with a Novel Congenital Disorder of Glycosylation (CDG) Type II Due to a Deep Intronic Splice Mutation in TMEM165. , 2013, JIMD reports.
[68] M. Baumgartner,et al. Inborn Metabolic Diseases , 1995, Springer Berlin Heidelberg.